• Raanan Berger, Israel | Chairperson

    Raanan Berger, Israel | Chairperson

    Dr. Raanan Berger is director of the Institute of Oncology at the Sheba Medical Center, which is Israel’s national hospital and the largest medical center in the Middle East. 
    Read More..
  • Aliza Ackerstein, Israel | Organizing Committee

    Aliza Ackerstein, Israel | Organizing Committee

    Aliza has an extensive career that spans over 30 years in the field of Life Sciences and Clinical Oncology...
  • Robin Foà, Italy I Organizing Committee

    Robin Foà, Italy I Organizing Committee

    Robin Foà is Professor of Hematology and Head of Hematology at the “Sapienza” University of Rome, Italy.
  • Talia Golan, Israel | Organizing Committee

    Talia Golan, Israel | Organizing Committee

    Talia is a clinician-scientist dedicated to advancing pancreatic cancer research, seeking to understand the cancer’s biology, with especially relevance to BRCA-associated tumors.
    Read More..
  • Michele Milella, Italy | Organizing Committee

    Michele Milella, Italy | Organizing Committee

    Dr. Milella graduated in Medicine and Surgery in 1992 and specialized in Medical Oncology in 1996. He received postdoctoral training at the University of Texas, M. D. Anderson Cancer Center
    Read More..
  • Jens Siveke, Germany | Organizing Committee

    Jens Siveke, Germany | Organizing Committee

    Jens Siveke is a physician-scientist focusing on preclinical and clinical research in solid tumors. He is Director of the Division of Solid Tumor Translational Oncology at the partner site Essen of the German Cancer Consortium (DKTK) and German Cancer Research Center (DKFZ) and head the clinical pancreatic cancer program at the West German Cancer Center, University Hospital Essen.
  • Daniela Abbiento, Italy

    Daniela Abbiento, Italy

    Daniela has more than 14 years’ experience in the CRO industry, mainly in the clinical monitoring environment with specific focus in Employee Management and Project Delivery. She holds the role of Site Relationship and Operational Lead within Merck KGaA
  • Gail Adinamis, USA

    Gail Adinamis, USA

    Gail Adinamis provides vision, leadership, strategic planning and oversight for GlobalCare Clinical Trials . Ms Adinamis is an accomplished executive with over 35 years of comprehensive phase I-IV clinical trials experience, including over 12 years of global clinical trials management at Abbott Laboratories and Astellas Pharma US. Ms Adinamis founded the business model for centrally managed in-home and alternate site services for clinical trials in 1992.
  • Donald Berry, USA

    Donald Berry, USA

    Donald Berry is professor in the Department of Biostatistics of the University of Texas M.D. Anderson Cancer Center. He received his Ph.D. in statistics from Yale University and has held endowed faculty positions at Duke University and M.D. Anderson. 
  • Gennaro Ciliberto, Italy

    Gennaro Ciliberto, Italy

    1978 M.D. Univ of Napoli "Federico II”
    1979-1987 Post doc Fellow EMBL Heidelberg
    1987-1990 Associate professor in Genetics, Univ of Pisa
    1990 Full Professor of Molecular Biology, Univ of Napoli, Faculty of Pharmacy. In year 1995 moved to Univ
    of Catanzaro.
  • Sabina Chiaretti

    Sabina Chiaretti

    I am currently an Assistant Professor in the Department of Cellular Biotechnologies and Hematology at the Sapienza University of Rome, Italy. 
  • Vincenzo Corbo, Italy

    Vincenzo Corbo, Italy

    Dr Vincenzo Corbo is assistant professor at the Department of Diagnostics and Public Health, University of Verona, Italy. He received his PhD from the University of Verona in 2009. In Verona, he contributed to set up next generations sequencing platforms in the lab of Professor Aldo Scarpa, where he participated to international efforts to describe somatic alterations of pancreas cancers.
  • Maria Craze, USA

    Maria Craze, USA

    Maria A Craze is the Headquarters Director of Global Data Operations at Merck & Company, Inc. She supports the Executive Director and leadership team, of this 530+ person organization, in managing the strategic and tactical priorities and projects throughout the organization in addition to directly supporting a US group of 30 data managers and management staff.  

  • Tamir Gilat, Israel

    Tamir Gilat, Israel

    Chairman of Israel Cancer Research Fund (ICRF)
    Tamir Gilat, 55 years old, is a lawyer and a businessman. 
    Degree in law from The Tel Aviv University and an EMBA from the Kellogg Management School – North Western University.
    Former professional football player (Goalie for Maccabi Tel Aviv).
    Tamir, father to 3 Daughters, lost his wife six months ago, attorney Keren Nahari, who passed away from breast cancer.
  • Aaron Goldman, USA

    Aaron Goldman, USA

    Aaron Goldman, PhD is heading research and development and immuno-oncology at Mitra Biotech, a personalized cancer medicine company headquartered in Boston MA, USA.
  • Jens Hoffmann, Germany

    Jens Hoffmann, Germany

    Dr. Hoffmann has special expertise for pharmacological investigations concerning endocrine tumors. Biomarker and translational research is another focus of his scientific work. He has published more than 50 original articles in peer reviewed journals and filed more than 30 patents.
  • Victoria Manax, USA

    Victoria Manax, USA

    Dr. Victoria Manax is the Chief Medical Officer of the Pancreatic Cancer Action Network. She provides strategic direction and operational oversight to the organization’s high-priority clinical initiatives, with emphasis on the Precision Promise initiative and its Clinical Trial Consortium. She works closely with clinical cancer research institutions and biopharmaceutical companies to build a productive and collaborative team that will accelerate progress toward the goal to double pancreatic cancer survival by 2020.
  • Ivana Matic, Belgium

    Ivana Matic, Belgium

    Ivana is a certified MD who has spent past 10 years in clinical research, gaining experience in various country and regional job roles at MSD. She holds a position of Global Operations Lead – Agreements, as well as the process ownership over site ready support with an accent on the contracts, informed consents, budgets. Ivana has spent significant time on-site which helped her understand the full scope of the activities needed for a successful trial conductance.
  • Simona Maria Paratore, Italy

    Simona Maria Paratore, Italy

    Simona Paratore is Medical Head for Cell and Gene Therapy in Novartis Oncology Region Europe. Simona works  in the oncology field from a Pharma perspective for more than 10 years and she contributed to the development and management of hematological products at country level . Simona holds a degree in Medicine  with a specialization in clinical Pharmacology from the University of Milan and an MBA degree from SDA Bocconi University in Milan. 
  • Rachel Schor-Bardach, Israel

    Rachel Schor-Bardach, Israel

    Rachel Schor-Bardach is a board-certified radiologist at the Chaim Sheba Medical Center, in the Oncological Imaging and Cross-Sectional Imaging Section. She works daily in close collaboration with the medical oncologists of the various malignancies, in order to constantly improve patient care and outcome.
  • Wendy Selig, USA

    Wendy Selig, USA

    Wendy K.D. Selig is Founder and CEO of WSCollaborative, a firm that focuses on defining and implementing strategies for establishing winning cross-sector collaborations in the health care arena.  Selig’s clients include non-profit organizations, trade associations and leading pharmaceutical and biotech companies. She is known for her collaborative approach to engagement, with a record of “connecting the dots” and fostering novel partnerships. 
  • Marcia Sherry-Newby, USA

    Marcia Sherry-Newby, USA

    Marcia Sherry-Newby’s quality-related career began when she was in college with a summer quality management position at the Del Monte factory in Oakland, CA in 1986, and continued in the food industry until she entered the pharmaceutical industry in 1992 as a safety officer for Sanofi-Winthrop. 
  • Diane Simeone, USA

    Diane Simeone, USA

    Diane Simeone is the Laura and Isaac Perlmutter Professor of Surgery and Pathology at New York University and the Director of the Pancreatic Cancer Center at NYU Langone Health.  
  • Marco Vignetti, Italy

    Marco Vignetti, Italy

    Director, Central Office, GIMEMA Research Foundation, Rome, Italy
    University Doctor / Researcher, Hematology Dept., University Hospital “Umberto I”, “Sapienza” University, Rome, Italy
    Vice-President, Italian Association against Leukemia, Lymphoma and Myeloma –Rome, Italy
  • Clemens-Martin Wendtner, Germany

    Clemens-Martin Wendtner, Germany

    Professor Clemens-Martin Wendtner is Professor of Medicine and Director of the Department of Hematology, Oncology, Immunology, Palliative Care, Infectious Diseases, and Tropical Medicine at the Klinikum Schwabing, Munich, an academic hospital of the University of Munich.
  • Michael Zaiac, Switzerland

    Michael Zaiac, Switzerland

    Vice President, Head of Haematology/Oncology Medical Affairs EMEA, Celgene
    Michael's responsibilities at Celgene encompass medical information, scientific communication and education, collaborative data generation and Celgene-sponsored studies operated by Medical Affairs across Celgene’s haematology and oncology franchise in the EMEA region.